Matt joined Osage University Partners in 2013. Prior to joining Osage, Matt was a strategy consultant with L.E.K. Consulting serving clients in biopharma, diagnostics, research tools, healthcare, and private equity. As a Ph.D. student, he studied the immune response to a novel smallpox vaccine.
University of Pennsylvania
Avid tennis and softball player, Penn State football die-hard